This $310,644 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to identify factors influencing parental hesitancy towards seasonal respiratory vaccines (SRVs) for children in the post-COVID-19 pandemic era. The project aims to: 1) determine the determinants of parental SRV hesitancy, 2) identify pediatricians' perceived challenges and...
This federal Project Grant award of $2,146,691 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund a study on the effects of the prenatal RSV prefusion F protein-based (RSVpreF) vaccine on neonatal, lactation, and child health outcomes. The study, conducted by HealthPartners Institute and involving sub-awards to Kaiser Foundation Research Institute and Allina Health System,...
This $1,266,296 project grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to model the impact of minor vaccine consent (VC) laws on COVID-19 vaccine uptake and transmission among adolescents.
The University of Pittsburgh, the primary awardee, will develop a comprehensive legal dataset of state and local VC laws, collaborate with community partners to...
This federal Project Grant award of $718,630.00 was made by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The funding supports a randomized controlled trial to evaluate the impact of a mobile chatbot, called iPrenatal+, on improving patient knowledge and uptake of prenatal genetic testing, particularly among English and Spanish-speaking pregnant people.
The key products and services...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $222,840 in funding to the University of Washington to investigate the associations between influenza vaccination during pregnancy and outcomes related to maternal influenza disease, infant anthropometry, and cost-effectiveness in rural Nepal.
The key products and services to be delivered under this 5-year award include: 1) assessing...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $2,082,128 to the University of Massachusetts Medical School (UMass Medical) to develop, implement, and evaluate a Motivational Interviewing (MI) training program for primary care providers (PCPs) to address COVID-19 and influenza vaccine hesitancy among vulnerable adult populations.
The key products and services to be...
The National Institute of Child Health and Human Development (NICHD) awarded a $384,000 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Innovation Research And Training, Inc. (IRT) to conduct a study examining parent-adolescent communication and shared decision-making about participation in pediatric clinical trials. The study will use videotaped observations, questionnaires, and interviews with 80 parent-adolescent pairs to investigate how positive and...
This $978,338 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a research initiative to develop an effective therapeutic vaccine for the prevention of secondary Mycobacterium tuberculosis (M.TB) infection. The research, conducted by Seattle Children's Research Institute, aims to screen 16 vaccine candidates consisting of 4 antigens and 4 adjuvants to identify optimized combinations that can...
This $286,791 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports the development and application of pediatric-specific blood transcriptional modules (PTBMs) through public data mining. The goal is to construct robust and widely applicable PTBMs that capture the heterogeneous physiological states of children aged 0-12 years across diverse geographical settings. This work aims to address...
This federal Project Grant award in the amount of $178,000 was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant will support research conducted by The Children's Hospital of Philadelphia (CHOP) to create a framework for early-life phenotyping of very preterm infants. The goal is to categorize infants into distinct phenotypes based on perinatal variables, and then...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $220,000.00 to support the development and testing of the "Presumptively Initiating Vaccines and Optimizing Talk for Inpatients (PIVOT-IN)" intervention.
The key products and services to be delivered through this award include:
A standardized screening approach to identify vaccine-eligible children during hospital stays.
A vaccine communication curriculum for inpatient clinicians to learn and use evidence-based techniques when discussing vaccines with hospitalized patients and families.
The intervention is being developed in collaboration with stakeholders at Seattle Children's Hospital, and will be tested through a prospective, season-matched, pre-post study to evaluate its effectiveness in improving routine vaccination of vaccine-eligible hospitalized children. The findings will inform future dissemination efforts and a larger multi-center trial.